In this paper we demonstrate that PB28 abolishes the Ca2+ release through the inositol 1,4,5-trisphosphate (InsP3) receptors and ryanodine receptors in SK-N-SH cells. Sigma receptors are divided into the subtypes sigma-1 and sigma-2, which are expressed in tumor cell lines and characterized by distinct pharmacological profiles. The sigma-1 receptor has been recently cloned, whereas the sigma-2 receptor is less well characterized. The endogenous ligand(s) of both subtypes remain unclear. In isolated guinea pig ileum, PB28 inhibits the contraction induced by carbachol dose dependently and in a non-competitive manner. In SK-N-SH cells PB28 challenge does not affect the intracellular Ca2+ concentration but incubation with PB28 for 45 min abolis...
A large number of drugs are known to bind with high affinity to sigma receptors (sigma-Rs) and have ...
Purpose: Metabotropic receptor agonists that signal through Gq-coupled pathways increase Ca2+ in mam...
Background: Despite considerable efforts by scientific research, pancreatic cancer is the fourth lea...
In this paper we demonstrate that PB28 abolishes the Ca2+ release through the inositol 1,4,5-trispho...
Sigma-1 receptors are specifically located at the endoplasmic reticulum–mitochondrion interface, but...
We demonstrate that F281, a synthetic agonist of the sigma-2 receptor (s2R), induces a non transient...
Sigma receptors are usually classified as a separate class of intracellular receptors. Among them th...
In hepatocytes, as in other cell types, Ca(2+) signaling is subject to complex regulations, which re...
Sigma1 receptors (σ1Rs) are expressed widely; they bind diverse ligands, including psychotropic drug...
Although sigma receptors were discovered in 1982, the biochemical and physiological roles of sigma r...
BACKGROUND AND PURPOSE: The Sigma-1 receptor (Sig1R) impacts on calcium ion signalling and has a ple...
Sigma receptors are widely distributed in the central nervous system where they modulate neurotransm...
Abstract Background Sigma-2 receptor ligands have been studied for treatment of pancreatic cancer be...
In the studies described in this thesis, the ability of muscarinic agonists to initiate phosphoinosi...
Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed through...
A large number of drugs are known to bind with high affinity to sigma receptors (sigma-Rs) and have ...
Purpose: Metabotropic receptor agonists that signal through Gq-coupled pathways increase Ca2+ in mam...
Background: Despite considerable efforts by scientific research, pancreatic cancer is the fourth lea...
In this paper we demonstrate that PB28 abolishes the Ca2+ release through the inositol 1,4,5-trispho...
Sigma-1 receptors are specifically located at the endoplasmic reticulum–mitochondrion interface, but...
We demonstrate that F281, a synthetic agonist of the sigma-2 receptor (s2R), induces a non transient...
Sigma receptors are usually classified as a separate class of intracellular receptors. Among them th...
In hepatocytes, as in other cell types, Ca(2+) signaling is subject to complex regulations, which re...
Sigma1 receptors (σ1Rs) are expressed widely; they bind diverse ligands, including psychotropic drug...
Although sigma receptors were discovered in 1982, the biochemical and physiological roles of sigma r...
BACKGROUND AND PURPOSE: The Sigma-1 receptor (Sig1R) impacts on calcium ion signalling and has a ple...
Sigma receptors are widely distributed in the central nervous system where they modulate neurotransm...
Abstract Background Sigma-2 receptor ligands have been studied for treatment of pancreatic cancer be...
In the studies described in this thesis, the ability of muscarinic agonists to initiate phosphoinosi...
Sigma receptors (subtypes sigma-1 and sigma-2) are a unique class of binding sites expressed through...
A large number of drugs are known to bind with high affinity to sigma receptors (sigma-Rs) and have ...
Purpose: Metabotropic receptor agonists that signal through Gq-coupled pathways increase Ca2+ in mam...
Background: Despite considerable efforts by scientific research, pancreatic cancer is the fourth lea...